» Articles » PMID: 33475474

Demographic, Regional and Temporal Trends of Hyperuricemia Epidemics in Mainland China from 2000 to 2019: a Systematic Review and Meta-analysis

Overview
Specialty Public Health
Date 2021 Jan 21
PMID 33475474
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hyperuricemia (HUA) is becoming a global public health problem and associated with multiple diseases.

Objective: We conducted a systematic review to synthesize the pooled prevalence of HUA in mainland China and delineate its demographic, regional, and temporal trends over the past two decades.

Methods: Systematic literature searches of PubMed, SCOPUS, Web of Science, the China National Knowledge Infrastructure (CNKI), and the Wanfang digital database were conducted to screen studies published from 1 January 2000 to 31 August 2019, reporting the prevalence of HUA in mainland China. The search strings were ('hyperuricemia' OR 'hyperuricaemia' OR 'uric acid') AND ('prevalence' OR 'epidemiology') AND 'China'. Article quality was appraised quantitatively from 11 items. Before formal meta-analysis, age-standardized prevalence was transformed. The random-effects model was applied to synthesize the pooled prevalence due to its high heterogeneity. Then we stratified the prevalence estimates by age, gender, area, nationality, and publication year for subgroup analysis.

Results: Totally 177 eligible studies with a whole population of 2,277,712 were included in the present meta-analysis. The pooled prevalence in mainland China was estimated at 16.4% (95% CI: 15.3%~17.6%). In studies with the onset age at 20 ~ 29 years old, males had a twice times higher HUA prevalence than females (21.5% vs. 8.9%). The prevalence of HUA was 13.7% (11.8%~15.7%) in people aged 15~ years old, 16.5% in 30~ (14.8%~18.4%), 17.9% in 40~ (16.4%~19.5%), 19.4% in 50~ (17.8%~21.0%), 20.5% in 60~ (18.8%~22.3%), and 24.9% in over 70 (22.9%~27.1%). Stratified by regions, southern (25.5%) and southwestern (21.2%) China shared the highest prevalence, and the lowest prevalence was observed in the northwest (12.6%). From 2001 to 2017, the prevalence estimates of HUA steadily climbed from 8.5% to 18.4% with minor fluctuations. Multiple regression revealed that HUA prevalence was positively correlated to the larger sample size, area, advanced onset age, and published year.

Conclusions: The last two decades witnessed the rapid growth prevalence of HUA in China. Early screening and personalized health education for HUA need to be given enough attention.

Citing Articles

Triglycerides and HDL Cholesterol Mediate the Association Between Waist Circumference and Hyperuricemia in Normal-Weight Men.

Cui W, Wang S, Gao L, Mu D, Li N, Pan F Diabetes Metab Syndr Obes. 2024; 17:4599-4610.

PMID: 39649757 PMC: 11621033. DOI: 10.2147/DMSO.S493327.


One-Year Risk Prediction of Elevated Serum Uric Acid Levels in Older Adults: A Longitudinal Cohort Study.

Zhang D, Xu X, Ye Z, Zhang Z, Xiao J Clin Interv Aging. 2024; 19:1951-1964.

PMID: 39605933 PMC: 11600923. DOI: 10.2147/CIA.S476806.


Effect of the Intake of Solid Block Dairy Products Like Cheese on Serum Uric Acid in Children: A Preliminary Mechanistic Investigation.

Lu Z, Tang Z, Guo X, Liu L, Cheng X, Yu L Nutrients. 2024; 16(22).

PMID: 39599650 PMC: 11597038. DOI: 10.3390/nu16223864.


Prevalence of and Risk Factors for Hyperuricemia in Urban Chinese Check-Up Population.

Feng T, Li C, Zheng J, Xu Y, Wang X, Li Y Int J Endocrinol. 2024; 2024:8815603.

PMID: 39512927 PMC: 11540885. DOI: 10.1155/2024/8815603.


Association between Body Mass Index and Serum Uric Acid: mediation analysis involving liver enzymes indicators.

Deng F, Wang Q, Wen X, Xu X, Jia L, He H BMC Public Health. 2024; 24(1):3007.

PMID: 39478457 PMC: 11526625. DOI: 10.1186/s12889-024-20457-1.


References
1.
Xie Y, Xu P, Liu K, Lin S, Wang M, Tian T . Hyperuricemia and gout are associated with cancer incidence and mortality: A meta-analysis based on cohort studies. J Cell Physiol. 2019; 234(8):14364-14376. DOI: 10.1002/jcp.28138. View

2.
Mallat S, Al Kattar S, Tanios B, Jurjus A . Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association. Curr Hypertens Rep. 2016; 18(10):74. DOI: 10.1007/s11906-016-0684-z. View

3.
Hommos M, Glassock R, Rule A . Structural and Functional Changes in Human Kidneys with Healthy Aging. J Am Soc Nephrol. 2017; 28(10):2838-2844. PMC: 5619977. DOI: 10.1681/ASN.2017040421. View

4.
Bardin T, Richette P . Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017; 15(1):123. PMC: 5494879. DOI: 10.1186/s12916-017-0890-9. View

5.
Choi J, Ford E, Gao X, Choi H . Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2008; 59(1):109-16. DOI: 10.1002/art.23245. View